Somatic coding mutations in human induced pluripotent stem cells
By A. Gore, Zhe Li, Ho-Lim Fung, Jessica E. Young, Suneet Agarwal, Jessica Antosiewicz-Bourget, I. Canto, Alessandra Giorgetti, Mason A. Israel, E. Kiskinis and 16 more. Nature, 2011
1,046 citations recorded by the source corpus.
Defined transcription factors can induce epigenetic reprogramming of adult mammalian cells into induced pluripotent stem cells. Although DNA factors are integrated during some reprogramming methods, it is unknown whether the genome remains unchanged at the single nucleotide level. Here we show that 22 human induced pluripotent stem (hiPS) cell lines reprogrammed using five different methods each contained an average of five protein-coding point mutations in the regions sampled (an estimated six protein-coding point mutations per exome). The majority of these mutations were non-synonymous, nonsense or splice variants, and were enriched in genes mutated or having causative effects in cancers. At least half of these reprogramming-associated mutations pre-existed in fibroblast progenitors at low frequencies, whereas the rest occurred during or after reprogramming. Thus, hiPS cells acquire genetic modifications in addition to epigenetic modifications. Extensive genetic screening should become a standard procedure to ensure hiPS cell safety before clinical use.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/c6c794a00230001183dff044d359149a0b9d3d5e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Detection and quantification of rare mutations with massively parallel sequencing (2011, background): “05% (33, 34), depending on factors such as the read length (35), use of improved base-calling algorithms (36–38), and the type of variants detected (39).”
- Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts (2011, background): “Recent data suggests that IPSCs may be more prone to genetic mutation and instability [11,12,13].”
- Ethical and Safety Issues of Stem Cell-Based Therapy (2018, background): “It is important to highlight here that due to the genomic instability of iPSCs [29], even improved protocols for their differentiation, does not guarantee safe clinical application and underlines several differences compared to hESCs [30-32].”
- Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations (2011, neutral): “More recently, it has been proposed that the reprogramming process itself compromises genomic integrity and leads to the accumulating of CNVs and somatic mutations (Gore et al., 2011; Hussein et al., 2011).”
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver (2015, neutral): “In iPS cells, an average of six base substitutions per line affect protein-coding DNA (Cheng et al., 2012; Gore et al., 2011).”
- Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014) (2014, background): “…P1035 [23] 93.7 2011 2014 4 Ieda et al. (2010) CELL, V142, P375 [22] 90.7 2011 2014 5 Lister et al. (2011) NATURE, V471, P68 [46] 90.1 2011 2014 6 Gore et al. (2011) NATURE, V471, P63 [17] 73.0 2011 2014 7 Slaughter et al. (2009) ADV MATER, V21, P3307 [47] 69.3 2011 2014 8 Polo et al. (2010) NAT…”